PlainRecalls
FDA Devices Moderate Class II Terminated

ETEST ETP32 (Ertapenem) Ref. 531640, 531600, blister packaging ETEST is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria (Only 531640 was distributed in the United States)

Reported: May 24, 2017 Initiated: April 25, 2017 #Z-2095-2017

Product Description

ETEST ETP32 (Ertapenem) Ref. 531640, 531600, blister packaging ETEST is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria (Only 531640 was distributed in the United States)

Reason for Recall

False susceptible results

Details

Recalling Firm
BioMerieux SA
Units Affected
3,238 units
Distribution
NATIONWIDE DISTRIBUTION TO AL, AZ, AR, CA, CO, CT, DE, DC, FL, GA, HI, IL, IN, IA, KS, KY, LA, M, MA, MD, MI, MN, MS, MO, MT, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, and WY
Location
Marcy L'Etoile

Frequently Asked Questions

What product was recalled?
ETEST ETP32 (Ertapenem) Ref. 531640, 531600, blister packaging ETEST is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria (Only 531640 was distributed in the United States). Recalled by BioMerieux SA. Units affected: 3,238 units.
Why was this product recalled?
False susceptible results
Which agency issued this recall?
This recall was issued by the FDA Devices on May 24, 2017. Severity: Moderate. Recall number: Z-2095-2017.